Latest Shareholder Participation News

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

Southern Palladium has raised A$20 million through a strategic share placement to accelerate its Bengwenyama PGM project, positioning the company for key milestones including a Final Investment Decision in 2026.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Reece Limited has completed a $365 million off-market share buy-back, repurchasing 4.3% of its shares at $13 each with no scale-back applied. This move returns excess capital to shareholders while preserving financial flexibility for future growth.

Shriro Holdings announces a $5 million off-market share buy-back at a 14.1% premium, signaling a pivot from acquisitions to expanding its BBQ range globally. The move aims to return excess capital to shareholders while maintaining flexibility for further buy-backs.

Aspermont Limited has completed its Share Purchase Plan and shortfall placement, raising over A$1 million to fund its digital transformation and AI-driven services expansion.

WAM Income Maximiser Limited has launched a Share Purchase Plan offering eligible shareholders a discounted entry point to increase their holdings, aiming to raise up to $48.1 million to fuel portfolio growth and deliver steady dividends.

WAM Income Maximiser Limited is offering eligible shareholders the chance to buy up to $30,000 in shares at a discount, aiming to raise $48.1 million to fuel growth and support monthly dividends.

Andromeda Metals has raised $13 million through a placement and launched a $2.5 million Security Purchase Plan to accelerate development of its Great White and High Purity Alumina projects.

Klevo Rewards has completed a partial entitlement offer, raising $1.77 million with underwriters covering 40% of the targeted $4.12 million capital raise. The company now faces decisions on allocating the remaining shortfall shares.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

MFF Capital Investments Limited has confirmed a fully franked dividend of AUD 0.09 per share for the six months ending June 2025, alongside updated Dividend Reinvestment and Bonus Security Plan prices.